Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-02-20 @ 1:34 PM
Study NCT ID:
NCT04012632
Status:
COMPLETED
Last Update Posted:
2019-07-11
First Post:
2019-07-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Kisspeptin/GPR54 Pathway and Early Puberty
Sponsor:
Shenzhen Center for Disease Control and Prevention
Organization:
Study Overview
Official Title:
Polymorphisms in the Kisspeptin/GPR54 Pathway Genes and the Risk of Early Puberty
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There was a worldwide early trend in girls'age for puberty onset. The timing of puberty onset varies greatly among individuals, and much of this variation is modulated by genetic factors. This study was designed to explored the association of polymorphisms in KISS1/GPR54 pathway genes and the risk of early puberty in Chinese Han girls.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: